CANagliflozin In DIALysis Patients
NCT07527390
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Dialysis
Chronic Kidney Disease (Stages 4 and 5)
Interventions
DRUG:
Invokana 300 mg and 100 mg tablet
Sponsor
University Medical Center Groningen